Search Results for "Fingolimod Hplc Method"

14:17 EDT 2nd July 2015 | BioPortfolio

Matching Channels

DNA-FISH Probes

Fluorescent in situ hybridization (FISH) is a sensitive and accurate technique that allows the detection of chromosome aberrations. In this method, a single-stranded fluorescent-labeled nucleic acid...

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Herpes simplex virus HSV 1 HSV 2 HHV 1 HHV 2

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the vira...

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...

ImuXen

ImuXen® is a liposomal technology platform designed to improve the delivery and effectiveness of DNA, protein and polysaccharide vaccines. Proof of concept preclinical studies with a number of...

Matching News

Cleaning Validation Method Using Swab Technique

A cleaning validation method has been developed for MICRO 90 Concentrated Cleaning Solution using a swab recovery technique and quantification with HPLC with charged aerosol detection (CAD) and mass s...

NEW ACE Method Development Kits for UHPLC / HPLC

ACE columns offer chromatographers an extremely powerful and reliable approach to UHPLC and HPLC method development. Based upon an ultra-inert, high efficiency silica, ACE phases incorporate the lates...

HPLC Column Addresses Difficult-to-Resolve Compounds

Phenomenex introduces the Kinetex C8 5-micron core-shell HPLC column. The used C8 phase delivers retention for the analysis of hydrophobic and “sticky” compounds. In combination with Kinetex Core-...

Routine Generation of Powder Samples from HPLC Fractions

Genevac reports that its HT Series II Evaporator using the Fast Lyophilisation, or LyoSpeed process is enabling a growing number of pharmaceutical labs to routinely dry HPLC fraction samples to a powd...

Phenomenex Kinetex EVO C18 columns

Phenomenex introduces 2.6 and 1.7 µm EVO C18 particle sizes, expanding the company’s Kinetex core-shell column family. The Kinetex EVO C18 columns offer good peak shape for bases, 100% aqueous stab...

Utilizing Fast HPLC Screening Methods for the Detection of Steroids

As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for phar...

VWR Acquires Hichrom Ltd.

VWR announced that it has acquired Hichrom, a leading manufacturer and distributor of HPLC columns and consumables. This acquisition builds upon VWR's existing chromatography systems, columns and cons...

How to Minimize HPLC Pump System Problems

High performance liquid chromatography requires extremely accurate pumping systems delivering an accurate, precise and pulse-free flow of the mobile phase. An HPLC pump system is a complex device with...

Matching PubMed Articles

Effects of Three Months Fingolimod Therapy on Heart Rate.

Fingolimod is a novel disease-modifying drug for relapsing-remitting multiple sclerosis (RRMS). Fingolimod initiation associates with a decrease in heart rate (HR). However, the long-term effects of f...

Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage.

Intracerebral hemorrhage (ICH) leads to high rates of death and disability. The pronounced inflammatory reactions that rapidly follow ICH contribute to disease progression. Our recent clinical trial d...

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.

To assess whether pretreatment-lymphocyte counts, treatment before fingolimod, age, sex, or body mass index (BMI) affects the risk of fingolimod-induced lymphopenia in patients with relapsing-remittin...

Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.

Background: To evaluate efficacy and safety of fingolimod for relapsing-remitting multiple sclerosis, particularly in patients previously exposed to natalizumab. Method: Prospective observational sing...

Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis.

Effect of fingolimod in multiple sclerosis (MS) is thought to involve the prevention of lymphocyte egress from lymphoid tissues, thereby reducing autoaggressive lymphocyte infiltration into the centra...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement